A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML
Clinical trial NCT02708641 · COMPLETED
Trial details
- NCT number
- NCT02708641
- Sponsor
- Michael Boyiadzis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-04
- Primary completion
- 2020-06-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.